CSAM is now accepting nomination submissions for the Vernelle Fox & Community Service Awards!

CSAM Vernelle Fox Award
Honoring an Inquiring Mind, Courage, and Enthusiasm

  • Inquiring Mind – Contributions to the understanding of the field
  • Courage – Resolution and tenacity
  • Enthusiasm – Energy for the positive

CSAM recognizes physicians who have made noteworthy and lasting contributions in line with the mission of the Society: contributions which improve the quality of health care services, increase communication and education among providers of care and add to the research on which the understanding of the field is based and on which the health care services are built.

This award will be presented to the selected candidate during the CSAM 2023 Addiction Medicine Review Course and Board Exam Preparation Track.

If you have someone in mind you feel is worthy of the Vernelle Fox Award, please CLICK HERE to submit a nomination on their behalf.

Please submit your nomination by June 14, 2024!

CSAM Community Service Award
Recognizing non-physicians who make outstanding contributions to the community

The Community Service award recognizes a non-physician who made outstanding contributions to the community. This CSAM award is presented based on merit and since 1985, it has been awarded to a wide variety of legislators, activists, community leaders, etc., all with one thing in common: they have improved the lives of those suffering from the disease of addiction, and by doing so have contributed a valuable service to the community.

This award will be presented to the selected candidate during the CSAM 2023 Addiction Medicine Review Course and Board Exam Preparation Track.

If you have someone in mind you feel is worthy of the Community Service Award, please CLICK HERE to submit a nomination on their behalf.

Please submit your nomination by June 14, 2024!

CSAM Legislative “Walk the Halls” Day

CSAM members “walked the halls” of the State Capitol in Sacramento on April 9, where they met with California legislators and their staff to discuss crucial bills making their way through the legislative process. CSAM Members Soraya Azari, MD, Delani Gunawardena, MD, Randy Holmes, MD, Raheel Khan, MD, Dymon Morgan, MD, (UCSF Fellow), Manu Saini, MD, and CSAM Legislative Advocate Robert Harris all took part in educating our elected officials. The group was able to meet with eight legislators and staff that include:

  • Senator Richard Roth (D-Riverside) – met with staff
  • Assemblymember Dr. Joaquin Arambula (D-Fresno)
  • Assemblymember Matt Haney (D-San Francisco) – met with staff
  • Assemblymember Mia Bonta (D-Oakland) – met with staff
  • Assemblymember Marc Berman (D-Menlo Park) – met with staff
  • Assemblymember Dr. Akilah Weber (D-San Diego) – met with staff
  • Senator Scott Wiener (D-San Francisco) and – met with staff
  • Assemblymember Dr. Jasmine Bains (D-Delano).

There were three main bills that were discussed, all of which CSAM supports:

AB 2651 (Bains) Support

AB 2651 would create, upon appropriation by the Legislature, the Licensed Alcohol Drug Counselor Board within the Department of Consumer Affairs. The bill would require the board to establish regulations and standards for the licensure of alcohol drug counselors, as specified. The bill would authorize the board to collaborate with the Department of Health Care Access and Information regarding behavioral health professions, review sunrise review applications for emerging behavioral health license and certification programs and refer complaints regarding behavioral health workers to appropriate agencies, as specified.

AB 2115 (Haney) Support

Under current law, specified clinics, including surgical clinics, may purchase drugs at wholesale for administration or dispensing to the clinic’s patients. Current law requires these clinics to maintain certain records and to obtain a license from the board. Current law prohibits specified substances from being dispensed by a nonprofit or free clinic, as defined. AB 2115 would authorize a nonprofit or free clinic to dispense a narcotic drug for the purpose of relieving acute withdrawal symptoms while arrangements are being made for referral for treatment, as described, and would require the clinic dispensing the narcotic to be subject to specified labeling and recordkeeping requirements. Because the bill would specify additional requirements under the Pharmacy Law, a violation of which would be a crime, it would impose a state-mandated local program.

AB 1842 (Reyes) Support

Current law authorizes health care service plans and health insurers that cover prescription drugs to utilize reasonable medical management practices, including prior authorization and step therapy, consistent with applicable law. AB 1842 would prohibit a medical service plan and a health insurer from subjecting a naloxone product or another opioid antagonist approved by the United States Food and Drug Administration, or a buprenorphine product or long-acting injectable naltrexone for detoxification or maintenance treatment of a substance use disorder, to prior authorization or step therapy. Because a willful violation of these provisions by a health care service plan would be a crime, this bill would impose a state-mandated local program.

All in all, it was a successful day of advocating for our profession and patients. As we all know, addiction medicine is a complex and challenging field that requires a deep understanding. That is why it is vital to have a Legislative Day where we can meet face to face with key legislators that shape the policies and regulations in the field of medicine. Thank you to all of the CSAM members that attended, and we hope to see you again next year!

Randy Holmes, MD, FAAFP, DFASAM
Chair, Committee on Government Affairs

CSAM Legislative Day – Sacramento – April 9

Join us for CSAM’s annual Legislative Day on Tuesday, April 9, 2024 at the State Capitol in Sacramento. Dr. Randy Holmes, Chair of CSAM’s Government Affairs Committee, and legislative advocate Robert Harris invite you to participate in individual meetings California legislators and their staff. This is a unique opportunity to collaborate with colleagues and educate California’s elected officials on crucial topics related to prevention, treatment, and access for our patients. There is no registration fee, and we need strong voices to join us for this important annual event. To RSVP or for inquiries, contact csam@csam-asam.org

CSAM Change in Management Announcement

For the past four years, CSAM’s Executive Director, Kim Andosca, and our staff have provided their services through the Advocacy & Management Group (AMG). We extend our gratitude to Kim and the team for their hard work and dedication to CSAM. However, in light of future considerations and after careful deliberation on CSAM’s evolving needs, the Board has decided to transition to new management. This means that Kim and her team will be concluding their service to CSAM in June 2024.

During this transition period, we are pleased to announce that we will be collaborating with Kerry Parker, CSAM’s former Executive Director, to facilitate a seamless transition and to begin the search for new management. Our primary objectives during this search process include exploring various management structures to ensure the fulfillment of CSAM’s mission and to secure our financial sustainability for the long term. We are committed to keeping you informed throughout this process, prioritizing transparency and inclusivity. Your active engagement and input are highly encouraged during this period of change. The following links provide downloadable PDFs of the Request for Proposals (RFPs) for Association Management Services, Conference Management, and the Executive Director position description. If you have any recommendations for qualified executive directors or management companies with a passion for addiction medicine, please reach out to us via email at ca.addictionmedicine@gmail.com.

During these changes, CSAM remains steadfast in its dedication to education and public policy advocacy. The Board and Conference Planning Committee are fully committed to delivering an exceptional CSAM State of the Art Conference, a tradition we are immensely proud of, scheduled for August 21-24 at the Hyatt Regency San Francisco. Having recently marked 50 years of service to the addiction medicine community and those they serve, we are excited to chart the course for the next 50 years of CSAM’s future alongside you.

Sincerely,
Sharone Abramowitz, MD, DFASAM
President, California Society of Addiction Medicine

Join Team DHCS!

DHCS is seeking a mission-driven MD/DO to guide DHCS’ ambitious agenda to ensure high-quality and accessible mental health and substance use disorder services in Medi-Cal and other public programs.

The Medical Consultant II position will provide clinical expertise and strategic advice to DHCS Behavioral Health leadership on the development and implementation of policy and initiatives designed to strengthen behavioral health care access, quality, and service delivery, and achieve equitable health care outcomes for 15 million Medi-Cal members and Californians served through other programs. The position, located within the Medi-Cal Behavioral Health Policy Division, will provide cross-cutting support to all DHCS Behavioral Health teams, and will collaborate across the Department and externally. The Medical Consultant II will shape the implementation of an unprecedented array of behavioral health funding investments, policy changes, and innovative initiatives that DHCS is leading to better meet the needs of the communities we serve. This is an incredible opportunity to support the change management process for a once-in-a-generation moment of behavioral health reform in California.

Full-time telework permitted. Board certifications in psychiatry and addiction medicine or addiction psychiatry preferred. For more information, please visit the Cal Careers website.

Please share with your networks. Thank you!

For any questions, please contact the DHCS Hiring Manager for this position, Jamie Shigetoshi, at Jamie.Shigetoshi@dhcs.ca.gov. Please feel free to cc Ivan Bhardwaj at Ivan.Bhardwaj@dhcs.ca.gov.

Medical Board of California Announcement:

Certain Licensing Documents Must be Submitted Online Starting January 1, 2024

The Direct Online Certification Submission (DOCS) service is a secure, fast, and reliable online document delivery system that allows medical schools and postgraduate training programs to submit certain primary-source licensing documents to the Board.


Effective January 1, 2024, the Board will only accept the following documents through DOCS for an open application, or through any of the other Board-accepted third party services identified on the Board’s website.


• Certificate of Medical Education (Form MED)
• Official Transcript
• Official English Translation of Transcript
• Postgraduate Training License Enrollment Form (Form EF)
• Certificate of Completion of ACGME/RCPSC/CFPC Postgraduate Training (Form PTA-B)
• Certificate of Completion of CODA Postgraduate Training (Form CODA1-CODA2)
• Current Postgraduate Training Verification (Form CTV)
• Explanation to Application Question (Form EXP)


The Board will not accept these documents if submitted by mail, which will delay the processing of the license application. The DOCS registration form is available on the Board’s website. DOCS registration forms and questions about registering may be emailed to docs@mbc.ca.gov.

DEA Hosts Public Listening Sessions on Telemedicine Regulations on September 12-13, 2023

WASHINGTON – The Drug Enforcement Administration will host public listening sessions to receive comments from healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine. The listening sessions will be held in person and livestreamed with remote participation available.

WHAT: Public Listening Sessions on Telemedicine Regulations
WHO: Open to the public
WHEN: September 12-13, 2023
WHERE: DEA Headquarters, 700 Army Navy Drive, Arlington, Va. 22202

FOR MEMBERS OF THE PUBLIC: Beginning on August 7, members of the public wishing to attend in person (space permitting) must register HERE by August 21, 2023 at 11:59 p.m. DEA is accepting requests to make limited oral presentations during the public meeting. Persons wishing to give an oral presentation – in person or virtually – time permitting, must indicate the desire to present when requesting to register. Presentations will be limited to 10 minutes.

Read More…

U.S. House Vote Tomorrow (May 25): Oppose Harsh Drug Penalties

FROM THE DRUG POLICY ALLIANCE:

The U.S. House will vote on the HALT Fentanyl Act tomorrow. This misguided bill would ramp up harsh mandatory minimum sentences for fentanyl analogues. And it would permanently make all fentanyl-related substances Schedule I without first testing them for benefits or harm. 

Criminalization has failed to keep us safer. Instead, it’s actually fueling the tragic overdose crisis. Increasing penalties will only make things worse. 

Saving lives requires a health approach, not more punishment. This bill is a step in the wrong direction. Help us to oppose it: tell your Representative to vote against the HALT Fentanyl Act right now.

We expect this vote to be close so it’s vital for constituents like you to also make…

Read More…